Activated protein C and the ovarian hyperstimulation syndrome: Possible therapeutic implications

Medical Hypotheses

Volumn 66, Issue 5, 2006, Pages 929-933

  Hitkari, Jason A ^a,b   Rowe, Timothy P ^a   Von Dadelszen, Peter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DROTRECOGIN; PROTEIN C;

BLOOD CLOTTING; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE INFERTILITY; HUMAN; IATROGENIC DISEASE; INFERTILITY THERAPY; INFLAMMATION; MEDICAL LITERATURE; OVARY HYPERSTIMULATION; PERFUSION; PRIORITY JOURNAL; REVIEW; THEORETICAL STUDY; THROMBOSIS;

EID: 32144450677     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.08.058     Document Type: Article

References (40)

1. J.G. Whelan, and N.F. Vlahos The ovarian hyperstimulation syndrome Fertil Steril 73 2000 883 896
2. A. Golan, R. Ron-el, A. Jerman, Y. Soffer, Z. Wienraub, and E. Caspi Ovarian hyperstimulation syndrome: an update review Obstet Gynaecol Surv 44 1989 430 440
3. D.N. Navot, A. Relou, A. Birkenfield, R. Rabinowitz, A. Brzezinski, and E.J. Margolioth Risk factors and prognostic variables in the ovarian hyperstimulation syndrome Am J Obstet Gynecol 159 1988 210 215
4. G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, and A. Lopez-Rodriquez Efficacy and safety of recombinant human activated protein C for severe sepsis New Engl J Med 344 2001 699 709
5. Activated protein C, Human. South Bend, IN, Enzyme Research Laboratories; 2001.
6. S. Kurosawa, C.T. Exmon, and D.J. Stearns-Kurosawa The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18 J Immunol 165 2000 4697 4703
7. C. Esmon The protein C pathway Crit Care Med 28 Suppl. 2000 S44 S48
8. F.B. Taylor Jr., H. Wada, and G. Kinasewitz Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC Crit Care Med 28 Suppl. 2000 S12 S19
9. K. Hirose, K. Okajima, Y. Taoka, M. Uchiba, H. Tagami, and K. Nakano Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation Ann Surg 232 2000 272 280
10. F. Espana, J. Gilabert, J. Aznar, A. Estelles, T. Kobayashi, and J.H. Griffin Complexes of activated protein C with α-1-antitrypsin in normal pregnancy and pre-eclampsia Am J Obstet Gynecol 164 1991 1310 1316
11. K. Strandberg, M. Kjellberg, R. Knebel, H. Lilja, and J. Stenflo A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor Thromb Haemostasis 86 2001 604 610
12. K. Strandberg, M. Kjellberg, E.M. Erb, U. Persson, D.F. Mosher, and B.O. Villoutreix Activated protein C-protein C inhibitor complex formation: characterization of a neoepitope provides evidence for extensive insertion of the reactive center loop Biochemistry 39 2000 15713 15720
13. J. Curvers, A.W. Nap, M.C. Thomassen, S.J. Nienhuis, K. Hamulyak, and J.L. Evers Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway Br J Haematol 115 2001 400 407
14. C. Biron, E. Galtier-Dereure, H. Rabesandratana, L. Bernard, P. Aluilar-Martinez, and J.F. Schved Hemostasis parameters during ovarian stimulation for in vitro fertilization: results of a prospective study Fertil Steril 67 1997 104 109
15. M.L. Wramsby, M.I. Bokarewa, M. Blomback, and A.K. Bremme Response to activated protein C during normal menstrual cycle and ovarian stimulation Hum Reprod 15 4 2000 795 797
16. A. Delvigne, K. Kostyla, A. De Leener, B. Lejeune, B. Cantiniaux, and P. Bergmann Metabolic characteristics of women who developed ovarian hyperstimulation syndrome Hum Reprod 17 2002 1994 1996
17. R.C. Bone, C.J. Grodzin, and R.A. Balk Sepsis: a new hypothesis for pathogenesis of the disease process Chest 112 1997 235 243
18. J.M. Stouthard, M. Levi, C.E. Hack, C.H. Veenhof, H.A. Romijn, and H.P. Sauerwein Interleukin-6 stimulates coagulation, not fibrinolysis, in humans Thromb Haemostasis 76 1996 738 742
19. P.R. Conkling, C.S. Greenberg, and J.B. Weinberg Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes Blood 72 1988 128 133
20. M.P. Bevilacqua, J.S. Pober, G.R. Majeau, W. Fiers, R.S. Cotran, and M.A. Gimbrone Jr. Recombinant tumor necrosis induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1 Proc Natl Acad Sci USA 12 1986 4533 4537
21. F. Fourrier, C. Chopin, J. Goudemand, S. Hendrycx, C. Caron, and A. Rime Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies Chest 101 1992 816 823
22. J.A. Lorente, L.J. Garcia-Frade, L. Landin, R. de Pablo, C. Torrado, and E. Renes Time course of hemostatic abnormalities in sepsis and its relation to outcome Chest 103 1993 1536 1542
23. S.M. Pride, C.S.H. James, and B.H. Yuen The ovarian hyperstimulation syndrome Semin Reprod Endocr 8 1990 247 260
24. J.A. Stewart, P.J. Hamilton, and A.P. Murdoch Thromboembolic disease associated with ovarian stimulation and assisted conception techniques Hum Reprod 12 1997 2167 2173
25. O.J. Inbar, D. Levran, S. Mashiach, and J. Dor Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome Fertil Steril 62 1994 1075 1076
26. M.H. Aurousseau, M.M. Samama, A. Belhassen, F. Herve, and J.N. Hugues Risk of thromboembolism in relation to an in vitro fertilization programme: three case reports Hum Reprod 10 1995 94 97
27. M. Mills, A. Eddowes, R. Fox, and P.G. Wardle Subclinical vein thrombosis after ovulation induction with gonadotropins Fertil Steril 56 1991 354 356
28. L.L. Phillips, W. Gladstone, and R.V. Wiele Studies of coagulation and fibrinolytic systems in hyperstimulation syndrome after administration of human gonadotropins J Reprod Med 14 1975 138 143
29. J. Balasch, J.C. Reverter, F. Fabregues, D. Tassies, A. Ordinas, and J.A. Vanrell Increased induced monocyte tissue factor expression by plasma from patients with severe ovarian hyperstimulation syndrome Fertil Steril 66 1996 608 613
30. H. Kodama, J. Fukuda, H. Karube, T. Matsui, Y. Shimizu, and T. Tanaka Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome Fertil Steril 66 1996 417 424
31. J. Balasch, V. Arroyo, F. Carmona, J. Llach, W. Jimenez, and J.C. Pare Severe ovarian hyperstimulation syndrome: role of peripheral vasodilatation Fertil Steril 56 1991 1077 1083
32. M. Dulitzky, S.B. Cohen, A. Inbal, D.S. Seidman, D. Soriano, and A. Lidor Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome Fertil Steril 77 2002 463 467
33. A. Tollan, N. Holst, F. Forsdahl, H.O. Fadnes, P. Oian, and J.M. Maltau Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization Am J Obstet Gynecol 162 1990 554 558
34. M.P. Goldsman, A. Pedram, C.E. Dominguez, I. Ciuffardi, E. Levin, and R.H. Asch Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome Fertil Steril 63 1995 268 272
35. N. McClure, D.L. Healy, P.A. Rogers, J. Sullivan, L. Beaton, and R.V. Haning Jr. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome Lancet 344 1994 235 236
36. B. Rizk, M. Aboulghar, J. Smitz, and R. Ron-El The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome Hum Reprod Update 3 1997 255 266
37. A. Revel, V. Barak, Y. Lavy, E. Anteby, Y. Abramov, and J.J. Schenker Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome Fertil Steril 66 1996 66 71
38. Y. Abramov, J.G. Schenker, A. Lewin, S. Friedler, B. Nisman, and V. Barak Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome Hum Reprod 11 1996 1381 1386
39. Y. Abramov, U. Elchalal, and J.G. Schenker Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study Fertil Steril 71 1999 645 651
40. T. Shigematsu, T. Kubota, and M. Aman Adult respiratory distress syndrome as a manifestation of ovarian hyperstimulation syndrome Int J Gynecol Obstet 69 2000 169 170